Πρωτεύουσες καρτέλες
Ο κατάλογος των δημοσιεύσεων είναι ενδεικτικός και μπορεί να μην περιλαμβάνει το σύνολο των δημοσιεύσεων.
Biochemical and imaging markers in patients with thalassaemia..
Hellenic J Cardiol.
(2020).
Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations..
ESC Heart Fail. 7(4), 1477-1487.
(2020).
From hybrid techniques to "hybrid" mentality: Modern strategies for perimembranous VSD interventions..
Int J Cardiol. 316, 70-71.
(2020).
When Both the Right Ventricle and the Pulmonary Artery "Light Up": A Case of Takayasu Arteritis..
Heart Lung Circ.
(2020).
Pregnancy still contraindicated in pulmonary arterial hypertension related to congenital heart disease: True or false?.
Eur J Prev Cardiol. 26(10), 1064-1066.
(2019).
Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge..
J Cardiovasc Pharmacol Ther. 24(3), 225-232.
(2019).
How to evaluate patients with congenital heart disease-related pulmonary arterial hypertension..
Expert Rev Cardiovasc Ther. 17(1), 11-18.
(2019).
Pulmonary arterial hypertension: the case for a bioelectronic treatment..
Bioelectron Med. 5, 20.
(2019).
Strength training in congenital heart disease: A way to boost respiratory function?.
Eur J Prev Cardiol. 26(5), 489-491.
(2019).
Pulmonary Arterial Hypertension in Connective Tissue Disorders: The emerging role of screening and early diagnosis. A position paper for Greek Rheumatologists..
Mediterr J Rheumatol. 30(2), 90-93.
(2019).
Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome..
Eur J Prev Cardiol. 2047487319891780.
(2019).
Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)..
Pulm Circ. 9(3), 2045894019877157.
(2019).
Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease..
Heart. 105(6), 465-469.
(2019).
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus..
Int J Cardiol. 297, 83-90.
(2019).
The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome..
Eur Respir J. 54(5),
(2019).
Practical Recommendations for the Diagnosis and Medical Management of Stable Angina: An Expert Panel Consensus..
J Cardiovasc Pharmacol. 74(4), 308-314.
(2019).
A gut feeling about children's exposure to hypertensive disorders of pregnancy in utero..
Eur J Prev Cardiol. 2047487319857213.
(2019).
Management of iron deficiency in chronic heart failure: Practical considerations for clinical use and future directions..
Eur J Intern Med. 65, 17-25.
(2019).
Hospitalization affects the anticoagulation patterns of patients with atrial fibrillation..
J Thromb Thrombolysis. 48(2), 225-232.
(2019).
Use of levosimendan in acute heart failure..
Eur Heart J Suppl. 20(Suppl I), I2-I10.
(2018).
Acquired cardiovascular disease in adult patients with congenital heart disease..
Heart. 104(7), 546-547.
(2018).
Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application..
Cardiovasc Drugs Ther. 32(6), 617-624.
(2018).
Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure..
Eur J Heart Fail. 20(3), 614-616.
(2018).